2020 Medicare Prescription Drug Price Information |
Express Scripts Medicare - Value (PDP) (S5660-113-0)
Benefit Details
 |
Monthly Premium: $55.10 Rx Deductible: $435 ICL: $4,020 Qualifies for LIS: No
Click on a letter below to view the Express Scripts Medicare - Value (PDP) Formulary
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
0-9
|
This Plan Uses Lower Cost-Sharing for Preferred Pharmacies |
UPTRAVI 200-800 TITRATION PACK  |
Plan’s average negotiated retail drug price in CMS PDP Region 11, includes: FL | $27,454.00* 30-Day Supply $33,196.80* 90-Day Supply
|
Formulary (Drug List) drug tier: | Tier #4: Non-Preferred Drug
|
Does this plan offer any Gap coverage? | No |
Does this drug have Gap coverage? | No, this drug IS NOT covered in the gap, but all drugs receive the donut hole discount. |
Drug Usage Management Restrictions: | Prior Authorization
|
Formulary (Drug List) Tier Cost-Sharing Details |
|
30-Day Supply Cost-Sharing |
90-Day Supply Cost-Sharing |
Preferred Pharmacy |
Standard Pharmacy |
Mail- Order** |
Preferred Pharmacy |
Standard Pharmacy |
Mail- Order** |
Initial $435 Deductible Cost Sharing: |
| 100% | 100% | 100% |
n/a | n/a | n/a |
Initial Coverage Phase Cost-Sharing: |
| 45% | 47% | 47% |
n/a | n/a | n/a |
Coverage Gap Phase Cost-Sharing Incl. Donut Hole Discount (Generics 75%): |
| 25% | 25% | 25% |
n/a | n/a | n/a |
Coverage Gap Phase Cost-Sharing Incl. Donut Hole Discount (Brand 75%): |
| 25% | 25% | 25% |
n/a | n/a | n/a |
Catastrophic Coverage Phase Cost-Sharing for Generic & Preferred Multi-Source Drugs: |
| The greater of 5% or $3.60 |
The greater of 5% or $3.60 |
Catastrophic Coverage Phase Cost-Sharing for Other Drugs (Brand-Name or Non-Preferred Multi-Source Drugs): |
| The greater of 5% or $8.95 |
The greater of 5% or $8.95 |
Your Estimated Cost for Purchases During Each Coverage Phase |
|
30-Day Supply Cost-Sharing |
90-Day Supply Cost-Sharing |
Preferred Pharmacy |
Standard Pharmacy |
Mail- Order** |
Preferred Pharmacy |
Standard Pharmacy |
Mail- Order** |
Your Estimated Cost in Deductible Phase: |
| $4,125.58 | $4,182.19 | $3,031.21 |
n/a | n/a | n/a |
Your Estimated Cost Initial Coverage Phase: |
| $3,936.70 | $2,709.54 | $2,709.54 |
n/a | n/a | n/a |
Your Estimated Cost in Gap if Drug is Generic (75% discount): |
| $6,452.70 | $6,452.70 | $6,452.70 |
$6,739.84 | n/a | n/a |
Your Estimated Cost in Gap if Drug is Brand-Name (75% discount): |
| $2,709.54 | $2,709.54 | $2,709.54 |
$2,913.97 | n/a | n/a |
Your Estimated Cost in Catastrophic Coverage Phase (Generic): |
| $1,372.70 | $1,372.70 | $1,372.70 |
n/a | n/a | n/a |
Your Estimated Cost in Catastrophic Coverage (Brand-Name or Non-Preferred Multi-Source Drugs): |
| $1,372.70 | $1,372.70 | $1,372.70 |
n/a | n/a | n/a |
Tier Cost-Sharing Details and Your Costs with Explanations |
|
30-Day Supply Cost-Sharing |
90-Day Supply Cost-Sharing |
Preferred Pharmacy |
Standard Pharmacy |
Mail- Order** |
Preferred Pharmacy |
Standard Pharmacy |
Mail- Order** |
--- If you purchase during the Initial Deductible Phase --- |
Initial $435 Deductible Cost Sharing: |
| 100% | 100% | 100% |
n/a | n/a | n/a |
Your Estimated Cost in Deductible Phase: |
| $4,125.58 | $4,182.19 | $3,031.21 |
n/a | n/a | n/a |
Explanation for 30-Day Preferred Pharmacy purchase: |
|
For a purchase of this drug made during the initial deductible phase,
you cross over into other phases of your plan’s coverage (straddle claim).
So you pay 100% of the drug cost up to your deductible of $435
and the remaining amount ($27,454.00-$435) (price - deductible) falls
into your initial coverage phase (ICP).
For the ICP portion of your coverage, your cost-sharing would be an additional $1,613.25
or $3,585.00 x 45%
(overage up to your remaining coverage limit
($3,585.00) * cost-sharing). Since the amount of the retail drug price falling into the ICP
$27,019.00 is greater than the remaining
initial coverage limit $3585 ($4,020 - $435),
$23,434.00 rolls into the coverage gap phase. For the portion that falls into the coverage gap phase,
you would pay an additional
$1,132.04
or ($4,528.16 x 25% -- 70% of the discount counts toward TrOOP and the 5% paid by your plan does not count toward TrOOP assuming this is a brand-name drug). Since the portion of the costs that fell into the coverage gap
$23,434.00 x 95% exceeds the amount
of TrOOP left ($4,301.75),
$18,905.84 falls into the catastrophic coverage phase. For the portion that falls into the catastrophic coverage phase, you would pay an additional $945.29 or (5% of $18,905.84) since it is greater than the minimum catastrophic cost-share of $8.95. |
--- If you purchase during the Initial Coverage Phase --- |
Initial Coverage Phase Cost-Sharing: |
| 45% | 47% | 47% |
n/a | n/a | n/a |
Your Estimated Cost Initial Coverage Phase: |
| $3,936.70 | $2,709.54 | $2,709.54 |
n/a | n/a | n/a |
Explanation for 30-Day Preferred Pharmacy purchase: |
| The cost-sharing for purchases made during the initial coverage phase (ICP) would be $1,809.00 or ($4,020.00 x 45%). But since the retail drug price ($27,454.00) is greater than initial coverage limit ($4,020), the difference of $23,434.00 rolls into the coverage gap phase. For the portion that falls into the coverage gap phase,
you would pay an additional
$1,195.00
or ($4,780.00 x 25% -- 70% of the discount counts toward TrOOP and the 5% paid by your plan does not count toward TrOOP). The portion of the costs that fell into the coverage gap $4,780.00 exceeds the amount of TrOOP left ($4,541.00) so you only pay in the gap on the amount within the TrOOP. The excess over TrOOP, $18,654.00 falls into the catastrophic coverage phase. For the portion that falls into the catastrophic coverage phase,
you would pay an additional $932.70 or (5% of $18,654.00) since it is greater than the minimum catastrophic cost-share of $8.95. So, your total cost for this one purchase is $3,936.70 or $1,809.00 (ICP) + $1,195.00 (Gap) + $932.70 (Cat.Cov.). |
--- If you purchase during the Coverage Gap Phase (Donut Hole) --- |
Your Estimated Cost in Gap if Drug is Generic (75% discount): |
| $6,452.70 | $6,452.70 | $6,452.70 |
$6,739.84 | n/a | n/a |
|
Since this drug’s negotiated retail price ($27,454.00) is greater than
the TrOOP limit ($6,350), in the donut hole phase, you would pay
$6,350.00 ($25,400.00 x 25%)
plus $102.70 in the catastrophic phase, (which is 5% of the remaining $2,054.00) because $102.70 is greater than the minimum catastrophic cost-share of $3.60. Although it rarely happens that you would be responsible for the entire $6,350 for a purchase in the coverage gap, it can occur, for example on an expensive generic drug with a $0 copay in the initial coverage phase. |
Your Estimated Cost in Gap if Drug is Brand-Name (75% discount): |
| $2,709.54 | $2,709.54 | $2,709.54 |
$2,913.97 | n/a | n/a |
|
Since 95% this drug’s negotiated
retail price ($27,454.00) is greater than
the TrOOP limit ($6,350), in the donut hole phase, you would pay
$1,671.05 (($6,350 / 95%) x 25% -- 70% of the discount counts toward TrOOP and the 5% paid by your plan does not count toward TrOOP)
plus $1,038.49 in the catastrophic phase, (which is 5% of the remaining
$20,769.79)
because $1,038.49 is greater than the minimum catastrophic cost-share of $8.95.
Although it rarely happens that you would be responsible for the entire
$6,350 for a purchase in the coverage gap, it can occur, for example
on an expensive generic drug with a $0 copay in the initial coverage phase. |
--- If you purchase during the Catastrophic Coverage Phase --- |
Catastrophic Coverage Phase Cost-Sharing for Generic & Preferred Multi-Source Drugs: |
| The greater of 5% or $3.60 |
The greater of 5% or $3.60 |
Your Estimated Cost in Catastrophic Coverage Phase (Generic): |
| $1,372.70 | $1,372.70 | $1,372.70 |
n/a | n/a | n/a |
Explanation for 30-Day Preferred Pharmacy purchase: |
| In the catastrophic coverage phase, you will pay the greater of 5% of the retail drug price or the minimum cost-share of $3.60. Calculating 5% of $27,454.00 = $1,372.70. Since $1,372.70 is more than $3.60, you would pay $1,372.70 for this drug at a preferred pharmacy, if it is a generic or preferred multi-source drug. |
Catastrophic Coverage Phase Cost-Sharing for Other Drugs (Brand-Name or Non-Preferred Multi-Source Drugs): |
| The greater of 5% or $8.95 |
The greater of 5% or $8.95 |
Your Estimated Cost in Catastrophic Coverage (Brand-Name or Non-Preferred Multi-Source Drugs): |
| $1,372.70 | $1,372.70 | $1,372.70 |
n/a | n/a | n/a |
Explanation for 30-Day Preferred Pharmacy purchase: |
| In the catastrophic coverage phase, you will pay the greater of 5% of the retail drug price or the minimum cost-share of $8.95. Calculating 5% of $27,454.00 = $1,372.70. Since $1,372.70 is more than $8.95, you would pay $1,372.70 for this drug at any pharmacy, if it is not a generic or preferred multi-source drug. |
Express Scripts Medicare - Value (PDP) Average Negotiated Retail Drug Price History |
| 30-Day Supply | 90 Day Supply |
September, 2020: | $27,454.00 | $33,196.80 |
June, 2020: | $27,476.00 | $33,285.60 |
March, 2020: | $27,556.00 | $83,280.00 |
January, 2020: | $26,404.00 | $80,160.00 |
September, 2019: | $26,399.30 | $79,972.10 |
June, 2019: | $26,475.40 | $80,123.60 |
March, 2019: | $25,991.80 | $94,514.80 |
January, 2019: | $24,650.70 | $88,830.40 |
September, 2018: | $24,650.80 | $88,830.40 |
June, 2018: | $24,650.80 | $88,830.50 |
March, 2018: | $25,201.20 | $77,266.90 |
January, 2018: | $23,181.70 | $71,139.90 |
September, 2017: | $23,269.30 | $71,405.40 |
June, 2017: | $23,287.70 | $71,389.30 |
March, 2017: | $22,413.40 | $68,428.60 |
January, 2017: | $22,459.90 | $68,616.40 |
September, 2016: | $22,755.92 | $68,121.92 |
June, 2016: | $22,792.09 | $68,035.98 |
April, 2016: | n/a | n/a |
January, 2016: | n/a | n/a |
September, 2015: | n/a | n/a |
June, 2015: | n/a | n/a |
April, 2015: | n/a | n/a |
January, 2015: | n/a | n/a |
September, 2014: | n/a | n/a |
June, 2014: | n/a | n/a |
March, 2014: | n/a | n/a |
January, 2014: | n/a | n/a |
October, 2013: | n/a | n/a |
January, 2013: | n/a | -- |
April, 2012: | n/a | -- |
September, 2010: | n/a | -- |
Notes: *The plan’s Average Retail Drug Price is based on three things: (1) the medication, (2) the specific Medicare Part D plan, and (3) the pharmacies in the plan’s service area. In this case, the average of the UPTRAVI 200-800 TITRATION PACK prices that the Express Scripts Medicare - Value (PDP) has negotiated with each of the retail pharmacies in the plan’s service area (CMS PDP Region 11, includes: FL).
In other words, when you use the Express Scripts Medicare - Value (PDP) to purchase UPTRAVI 200-800 TITRATION PACK, you may pay slightly more or slightly less than the figures shown in the table above depending on the pharmacy where you fill your prescription.
**The mail-order cost-sharing is the plan’s "preferred" mail-order cost-sharing.
|
Return to the Express Scripts Medicare - Value (PDP) 2020 Formulary Browser by choosing a letter below:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
0-9
|